Showing 2,371 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

The biology of HIV transmission

HIV Transmitted Through Heterosexual Sex May Initially Be ‘Fitter,’ but Likely Has No Effect on Prevention and Treatment

Editor's pick
TheBodyPro
26 April 2022
The search for a cure

Antibody therapy controls HIV for months in new clinical trial

Editor's pick
The Rockerfeller University
22 April 2022
Antibody-based treatment

New approach for delivery of anti-HIV antibody therapy shows promise in phase I clinical trial

Editor's pick
EurekAlert
13 April 2022
The search for an HIV prevention vaccine

Media Headlines Often Suggest That HIV Vaccines and Cures Are Imminent. Not So Fast!

Editor's pick
TheBody
1 April 2022
Injectable & long-acting HIV treatment

Bi-Monthly Injectable HIV-Treatment Drug Cabenuva Listed On Australia's PBS

Editor's pick
Star Observer
1 April 2022
New & experimental HIV treatments

After FDA hold, CytoDyn will appeal for pharma partnerships to save leronlimab

Editor's pick
FierceBiotech
31 March 2022
Injectable & long-acting HIV treatment

US: Cabenuva Approval Expanded to Include Adolescents With HIV

Editor's pick
Monthly Prescribing Reference
31 March 2022
Changing treatment

Outcomes of HIV Virologic Suppression After Switching to Dolutegravir/Lamivudine

Editor's pick
Infectious Disease Advisor
28 March 2022
Injectable & long-acting HIV treatment

ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in period

Editor's pick
ViiV press release
25 March 2022
Economic & social inequality

Income May Be the Biggest Determinant of Whether Women Stay on PrEP

Editor's pick
POZ
18 March 2022
Treatment outcomes & life expectancy

Readmission, Mortality are Post-Discharge Risks for HIV Patients

Editor's pick
Contagion Live
17 March 2022
Injectable & long-acting HIV treatment

US: Bottlenecks are slowing switch to GSK's long-acting HIV injectable Cabenuva: clinician

Editor's pick
FiercePharma
9 March 2022
New & experimental HIV treatments

U.S. FDA declines to approve Gilead's HIV drug on glass vial concerns

Editor's pick
Reuters
1 March 2022
Drug interactions & pharmacokinetics

No Interactions Between Hormone Therapy and PrEP in Transgender Women or Men

Editor's pick
NATAP
24 February 2022
Bad science & bogus treatments

Fact Check - Australia halted the development of a COVID-19 vaccine in December 2020

Editor's pick
Reuters
16 February 2022
Coronavirus

Fact Check - COVID-19 boosters do not cause positive HIV tests

Editor's pick
Reuters
14 February 2022
Neurological & cognitive problems

Telomere shortening associated with TAF but not TDF in CHARTER study

Editor's pick
i-Base
14 February 2022
Injectable & long-acting HIV treatment

Interim BHIVA guidance on long-acting cabotegravir/rilpivirine (LA-CAB/RPV) for antiretroviral therapy

Editor's pick
BHIVA
7 February 2022
Treatment outcomes & life expectancy

Improvements in survival for people with HIV continue to be achieved

Editor's pick
CATIE
2 February 2022
Injectable & long-acting HIV treatment

ViiV Healthcare announces US FDA approval of Cabenuva (cabotegravir, rilpivirine) for use every two months, expanding the label of the first and only complete long-acting HIV treatment

Editor's pick
ViiV press release
1 February 2022
New & experimental HIV treatments

Antiviral Efficacy, Safety, Tolerability of a Novel HIV-1 Maturation Inhibitor (GSK'254)

Editor's pick
Infectious Disease Advisor
31 January 2022
Pharmaceutical industry

CytoDyn board ousts CEO after a wild year, leaving an albatross of a C-suite job to fill

Editor's pick
FierceBiotech
27 January 2022
Pregnancy and vertical transmission

Updated US Guidelines: TAF In, Cabenuva Out for Pregnant People

Editor's pick
POZ
25 January 2022
Bad science & bogus treatments

Zimbabwe: NAC Discourages HIV Supplements

Editor's pick
AllAfrica
25 January 2022